DIN 02505541 — REBLOZYL 25 MG
REBLOZYL is a powder for solution of Luspatercept marketed by BRISTOL-MYERS SQUIBB CANADA. The full Luspatercept monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02505541
- Brand name
- REBLOZYL
- Active ingredient
- Luspatercept
- Strength
- 25 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Erythroid maturation agent (activin receptor ligand trap)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Luspatercept products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02505568 | REBLOZYL | 75 MG | POWDER FOR SOLUTION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |